I now have enough context from the medical library. Let me compile the comprehensive answers for all questions.Here are the complete answers to your Second Terminal Examination paper, organized exactly as per the mark distribution.
DEPARTMENT OF PHYSIOLOGY
Second Terminal Examination - MBBS Batch 2025-26
Time: 2:40 Hrs | Max. Marks: 80
Q.1 Essay Type Question (5 + 4 + 3 + 3 = 15 marks)
Part A: Diagrams of Ascending Tracts + Differentiation (5 marks)
The ascending (sensory) tracts of the spinal cord carry information from peripheral receptors to the brain. There are two major systems:
1. Dorsal Column - Medial Lemniscal (DCML) Pathway
Receptor → First-order neuron → Dorsal column (same side)
→ Nucleus gracilis / cuneatus (Medulla) → Decussation
→ Medial lemniscus → Thalamus (VPL) → Somatosensory cortex
- Travels IPSILATERALLY in the spinal cord, crosses at the medulla
- Gracile fasciculus (T7 and below); Cuneate fasciculus (T6 and above)
2. Spinothalamic Tract (Anterolateral Pathway)
Receptor → First-order neuron → Dorsal horn synapse
→ Decussation (within 1-2 segments) → Contralateral anterolateral column
→ Thalamus (VPL) → Somatosensory cortex
- Crosses at the SPINAL CORD LEVEL (near entry)
3. Spinocerebellar Tracts
- Anterior (Gower's tract): Crosses twice - ipsilateral representation
- Posterior (Flechsig's tract): Uncrossed, travels in posterolateral column
Diagram (Spinal cord cross-section):
POSTERIOR
[Dorsal columns]
[ G | C ]
/ \
[SCT post] [SCT ant]
\ /
[SThT] [CST desc]
ANTERIOR
G = Gracile; C = Cuneate; SCT = Spinocerebellar; SThT = Spinothalamic
Differentiation Table:
| Feature | DCML | Spinothalamic | Spinocerebellar |
|---|
| Location | Posterior column | Anterolateral | Posterolateral / Anterior |
| Decussation | At medulla | At spinal cord | Does not cross (posterior) |
| 1st synapse | Medulla | Dorsal horn | Dorsal horn (Clarke's nucleus) |
| 2nd synapse | Thalamus (VPL) | Thalamus (VPL) | Cerebellum (no thalamus) |
Part B: Sensations Carried (4 marks)
| Tract | Sensations Carried |
|---|
| Dorsal Column (DCML) | Fine/discriminative touch, proprioception, vibration sense, two-point discrimination, stereognosis, graphesthesia |
| Lateral Spinothalamic | Pain and temperature (crude) |
| Anterior Spinothalamic | Crude touch, pressure, tickle |
| Posterior Spinocerebellar | Unconscious proprioception from lower limbs (muscle spindles, GTO) |
| Anterior Spinocerebellar | Unconscious proprioception from lower limbs (GTO predominantly) |
| Spinoreticular | Diffuse, poorly localized pain (arousal component) |
Part C: Brown-Sequard Syndrome (3 marks)
Definition: Hemisection (half-section) of the spinal cord resulting in a characteristic pattern of ipsilateral and contralateral deficits below the level of lesion.
Classic Features (e.g., Right-sided lesion at T5):
| Feature | Side | Mechanism |
|---|
| Ipsilateral spastic paralysis (UMN) | Right (same side) | Corticospinal tract is ipsilateral below decussation in medulla |
| Ipsilateral loss of fine touch, vibration, proprioception | Right (same side) | DCML crosses at medulla, so cord injury = ipsilateral loss |
| Contralateral loss of pain and temperature | Left (opposite side) | Spinothalamic tract crosses within 1-2 segments of entry |
| Ipsilateral LMN signs at lesion level | Right, at T5 only | Anterior horn cell damage at that segment |
| Ipsilateral vasodilation/anhidrosis | Right | Disruption of descending autonomic fibers |
Causes: Penetrating trauma (stab wound), MS, cord tumors, disc herniation, radiation myelopathy.
Note: Pure hemisection is rare; "Brown-Sequard Plus" (incomplete variant) is more common in clinical practice.
Q.2 Clinical Case Scenario (1 + 3 + 6 + 3 + 2 = 15 marks)
Case: 50-year-old obese male with weakness, polydipsia, polyuria, polyphagia, weight loss, delayed wound healing. FBG: 170 mg/dl; HbA1c: 7.9%; LDL: 140 mg/dl.
Part (a): Probable Diagnosis (1 mark)
Type 2 Diabetes Mellitus (T2DM)
Rationale: FBG ≥ 126 mg/dl (here 170 mg/dl) + HbA1c ≥ 6.5% (here 7.9%) in an obese middle-aged male with the classic triad of polyuria, polydipsia, polyphagia, plus weight loss and impaired healing.
Part (b): Physiological Basis of Symptoms (3 marks)
| Symptom | Physiological Basis |
|---|
| Polyuria | Hyperglycemia exceeds renal threshold (~180 mg/dl) → glucose spills into urine → osmotic diuresis → increased urine output |
| Polydipsia (Increased thirst) | Osmotic diuresis → dehydration → rise in plasma osmolarity → stimulates osmoreceptors in hypothalamus → ADH release + thirst |
| Polyphagia (Increased appetite) | Lack of insulin signaling → cells cannot uptake glucose → "cellular starvation" despite high blood glucose → hypothalamus signals hunger |
| Weight loss | Insulin deficiency → decreased glucose uptake → increased lipolysis (fat breakdown) + protein catabolism → net weight loss |
| Weakness | Inadequate glucose delivery to muscles → reduced energy production (ATP) → weakness and fatigue |
| Delayed wound healing | Impaired leukocyte function (reduced chemotaxis, phagocytosis), microvascular disease reducing blood supply, reduced collagen synthesis → poor healing |
Part (c): Functions of Insulin (6 marks)
Insulin is a polypeptide hormone secreted by beta cells of islets of Langerhans. It is the primary anabolic hormone of the body.
I. Effects on Carbohydrate Metabolism (2 marks)
- Increases GLUT-4 mediated glucose uptake by muscle and adipose tissue
- Stimulates glycogenesis (glucose → glycogen) in liver and muscle
- Inhibits gluconeogenesis and glycogenolysis in liver
- Stimulates glycolysis (glucose oxidation for energy)
- Net effect: Lowers blood glucose
II. Effects on Fat Metabolism (2 marks)
- Stimulates lipogenesis (triglyceride synthesis) in adipose tissue
- Inhibits hormone-sensitive lipase → inhibits lipolysis
- Increases LPL (lipoprotein lipase) activity → increases fat storage
- Inhibits ketogenesis
- Net effect: Anti-lipolytic and pro-lipogenic
III. Effects on Protein Metabolism (1 mark)
- Stimulates amino acid uptake by cells
- Stimulates protein synthesis (anabolic effect)
- Inhibits protein catabolism and gluconeogenesis from amino acids
- Net effect: Positive nitrogen balance, promotes growth
IV. Other Effects (1 mark)
- Promotes K+ uptake into cells (hypokalemia in excess insulin)
- Stimulates cell growth and proliferation
- Promotes sodium and water retention (contributes to hypertension in insulin resistance)
- Stimulates hypothalamic satiety centers
Part (d): Oral Glucose Tolerance Test (OGTT) (3 marks)
Definition: A standard test to assess body's ability to metabolize glucose after an oral glucose load.
Procedure:
- Patient fasts for 8-14 hours overnight
- Fasting blood glucose measured (baseline)
- 75 g of glucose dissolved in 250-300 mL water is given orally
- Blood glucose measured at 30 min, 1 hour, and 2 hours post-ingestion
Interpretation (WHO criteria):
| Result | Fasting | 2-hour Post-Load |
|---|
| Normal | < 100 mg/dl | < 140 mg/dl |
| Impaired Fasting Glucose | 100-125 mg/dl | - |
| Impaired Glucose Tolerance (Pre-diabetes) | - | 140-199 mg/dl |
| Diabetes Mellitus | ≥ 126 mg/dl | ≥ 200 mg/dl |
Clinical Use:
- Diagnosis of T2DM and gestational diabetes
- Diagnosis of pre-diabetes (IGT/IFG)
- Screening in high-risk populations (obese, family history, hypertensive)
- In pregnancy: 75g OGTT at 24-28 weeks (Carpenter-Coustan criteria)
Normal OGTT curve: Peak at 30-60 min, returns to baseline by 2 hours.
Part (e): Metabolic Syndrome (2 marks)
Definition: A cluster of metabolic abnormalities that together significantly increase the risk of cardiovascular disease and T2DM.
Diagnostic Criteria (IDF / NCEP-ATP III - requires any 3 of 5):
| Component | Threshold |
|---|
| Central obesity | Waist circumference >102 cm (men) / >88 cm (women); BMI >30 kg/m² |
| Elevated fasting blood glucose | ≥ 100 mg/dl OR on diabetes treatment |
| Hypertension | ≥ 130/85 mmHg OR on antihypertensive treatment |
| Low HDL cholesterol | < 40 mg/dl (men) / < 50 mg/dl (women) |
| Elevated triglycerides | ≥ 150 mg/dl OR on lipid-lowering treatment |
Pathophysiology: Central (visceral) obesity → insulin resistance → compensatory hyperinsulinemia → hypertension, dyslipidemia, hyperglycemia.
This patient meets criteria: obese + elevated FBG (170) + elevated LDL → likely also has other components.
Q.3 Short Notes (6 × 5 = 30 marks)
(a) Types of Hypoxia (5 marks)
Definition: Hypoxia is a condition in which the oxygen supply to tissues is inadequate for their metabolic needs.
Classification and Differentiation:
| Type | Definition | PaO₂ | O₂ Saturation | O₂ Content | A-V O₂ diff | Example |
|---|
| Hypoxic (Hypoxemia) | Reduced PaO₂ due to inadequate oxygenation in lungs | Low | Low | Low | Increased | High altitude, hypoventilation, COPD, V/Q mismatch |
| Anemic | Normal PaO₂ but reduced O₂-carrying capacity (low Hb) | Normal | Normal | Low | Increased | Anemia, CO poisoning, methemoglobinemia |
| Stagnant (Ischemic) | Normal O₂ content but reduced blood flow/delivery | Normal | Normal | Normal | Increased | Heart failure, shock, local ischemia |
| Histotoxic | Tissues unable to utilize O₂ despite normal delivery | Normal | Normal | Normal | Decreased (venous O₂ high) | Cyanide poisoning (blocks cytochrome oxidase) |
| Demand hypoxia | O₂ demand exceeds supply during extreme exercise | Normal/Low | Normal/Low | Normal | Increased | Strenuous exercise |
Key differentiating point: In histotoxic hypoxia, venous PO₂ is HIGH (oxygen not being used), unlike all others where venous O₂ is low.
Affinity hypoxia (additional type): CO poisoning shifts O₂-Hb curve left, preventing O₂ unloading at tissues.
(b) Visual Pathway with Lesions (5 marks)
Pathway:
Retina → Optic Nerve (CN II) → Optic Chiasm → Optic Tract
→ Lateral Geniculate Nucleus (LGN) of Thalamus
→ Optic Radiation (Geniculocalcarine tract)
→ Primary Visual Cortex (Area 17, Calcarine sulcus, Occipital lobe)
Key anatomical note: Nasal (medial) fibers decussate at the optic chiasm; Temporal (lateral) fibers remain ipsilateral.
Lesions and Visual Field Defects:
| Site of Lesion | Visual Defect | Example Cause |
|---|
| 1. Optic nerve | Monocular blindness (same eye) | Optic neuritis, trauma |
| 2. Optic chiasm (central) | Bitemporal hemianopia ("tunnel vision") | Pituitary adenoma, craniopharyngioma |
| 3. Optic tract | Contralateral homonymous hemianopia (incongruous) | Trauma, tumor |
| 4. Meyer's loop (temporal lobe) | Contralateral superior quadrantanopia ("pie in the sky") | Temporal lobe tumor |
| 5. Parietal optic radiation | Contralateral inferior quadrantanopia ("pie on the floor") | Parietal lobe tumor |
| 6. Visual cortex (complete) | Contralateral homonymous hemianopia WITH macular sparing | MCA/PCA infarct |
Diagram representation:
LEFT EYE RIGHT EYE
[L] [N] [N] [R]
↓ ↓
[Optic Nerve] [Optic Nerve]
↓
[Optic Chiasm] ← Nasal fibers cross
↓
[L Optic Tract] [R Optic Tract]
↓ ↓
[LGN] [LGN]
↓ ↓
[Optic Radiation] [Optic Radiation]
↓ ↓
[L Visual Cortex] [R Visual Cortex]
(c) Functions of Gastrin, Cholecystokinin (CCK), and Secretin (5 marks)
1. GASTRIN
- Source: G cells of antrum of stomach + duodenum
- Stimulus: Protein/peptides in stomach, vagal stimulation, gastric distension, hypercalcemia
- Functions:
- Stimulates HCl secretion by parietal cells (main function)
- Stimulates pepsinogen secretion by chief cells
- Promotes gastric motility
- Trophic (growth) effect on gastric mucosa
- Stimulates insulin secretion
- Inhibited by: pH < 3.0 (negative feedback), somatostatin, secretin
2. CHOLECYSTOKININ (CCK)
- Source: I cells of duodenum and jejunum
- Stimulus: Fat and protein (digestion products) in duodenum
- Functions:
- Gallbladder contraction and bile release (main function)
- Relaxation of sphincter of Oddi
- Stimulates pancreatic enzyme secretion (amylase, lipase, proteases)
- Augments action of secretin on pancreatic bicarbonate
- Inhibits gastric emptying (slows entry of food into duodenum)
- Satiety signal to hypothalamus (reduces appetite)
3. SECRETIN
- Source: S cells of duodenum
- Stimulus: Acid (low pH) entering duodenum from stomach; fat
- Functions:
- Stimulates pancreatic ductal cells to secrete bicarbonate-rich juice (main function - neutralizes acidic chyme)
- Stimulates liver to secrete bile (volume, not composition)
- Inhibits gastric HCl secretion
- Inhibits gastric motility and emptying
- Augments CCK-stimulated pancreatic enzyme secretion
(d) Properties of Synapse (Any 4) (5 marks)
A synapse is the specialized junction between two neurons (or neuron and effector) where signal transmission occurs.
1. Unidirectional Transmission
- Impulses travel only from pre-synaptic to post-synaptic neuron (orthodromic transmission)
- Due to the presence of neurotransmitter vesicles only in the pre-synaptic terminal and receptors only on post-synaptic membrane
- Prevents feedback/reverse conduction
2. Synaptic Delay
- A delay of 0.5-1 ms occurs at each synapse
- This is the time required for: Ca²+ influx → vesicle fusion → NT release → NT diffusion → receptor binding → generation of EPSP/IPSP
- Total delay in a reflex arc can be estimated from number of synapses × 0.5 ms
3. Summation
- A single EPSP is usually insufficient to generate an action potential
- Temporal summation: Rapid successive impulses from ONE pre-synaptic neuron summate
- Spatial summation: Simultaneous impulses from MULTIPLE pre-synaptic neurons summate
- Both types can reach threshold to fire the post-synaptic neuron
4. Fatigue
- With high-frequency repetitive stimulation, synaptic transmission decreases over time
- Causes: depletion of neurotransmitter vesicles, desensitization of post-synaptic receptors, accumulation of metabolic waste
- Protective mechanism: prevents overexcitation of target neurons
5. Convergence and Divergence (bonus)
- Convergence: Multiple pre-synaptic neurons synapse on a single post-synaptic neuron (integration)
- Divergence: One pre-synaptic neuron synapses on multiple post-synaptic neurons (amplification)
(e) Disorders of Glucocorticoid Hyper- and Hyposecretion (5 marks)
HYPERSECRETION - Cushing's Syndrome/Disease
Definition: Excess cortisol (the principal glucocorticoid) from any cause.
Causes:
- Cushing's Disease: Pituitary adenoma secreting excess ACTH (most common, 70%)
- Ectopic ACTH syndrome: Small cell lung cancer, carcinoid tumors
- Adrenal tumor: Cortisol-secreting adrenal adenoma/carcinoma
- Iatrogenic: Long-term corticosteroid therapy (most common overall cause)
Clinical Features (due to excess cortisol):
| Feature | Mechanism |
|---|
| Central obesity, moon face, buffalo hump | Redistribution of fat to trunk |
| Hyperglycemia ("steroid diabetes") | Increased gluconeogenesis, insulin resistance |
| Muscle wasting, proximal myopathy | Protein catabolism |
| Osteoporosis | Inhibition of osteoblasts, increased Ca²+ excretion |
| Hypertension | Na⁺ and water retention (mineralocorticoid effect) |
| Striae (purple) | Skin fragility from protein catabolism |
| Immunosuppression | Anti-inflammatory, reduced lymphocytes |
| Mood changes, psychosis | Direct CNS effect |
| Hirsutism, menstrual irregularities | Excess adrenal androgens (if ACTH excess) |
HYPOSECRETION - Addison's Disease (Primary Adrenocortical Insufficiency)
Definition: Destruction or dysfunction of the adrenal cortex leading to deficiency of cortisol AND aldosterone.
Causes: Autoimmune (80%, commonest), TB (historical), HIV, bilateral adrenalectomy, adrenal hemorrhage (Waterhouse-Friderichsen syndrome - meningococcemia)
Clinical Features:
| Feature | Mechanism |
|---|
| Weakness, fatigue | Lack of cortisol → reduced gluconeogenesis → hypoglycemia |
| Hyperpigmentation (hallmark of Addison's) | Low cortisol → elevated ACTH + MSH → melanocyte stimulation |
| Hypotension | Aldosterone deficiency → Na⁺ and water loss |
| Hyponatremia, hyperkalemia | Aldosterone deficiency |
| Anorexia, nausea, vomiting | Non-specific GI symptoms |
| Salt craving | Aldosterone deficiency |
| Addisonian crisis | Acute cortisol deficiency → life-threatening hypotension, shock |
Note: Secondary adrenal insufficiency (pituitary ACTH deficiency) does NOT cause hyperpigmentation (ACTH is low) and does NOT cause hyperkalemia (aldosterone axis intact).
Q.4 Short Answer Type Questions (4 × 5 = 20 marks)
(a) Methods of Measurement of Cardiac Output (5 marks)
Normal CO: 5 L/min (at rest); Cardiac Index = CO/BSA = 2.5-4.0 L/min/m²
1. Fick's Principle (Direct Fick Method)
- Formula: CO = O₂ consumed per min / (Arterial O₂ content - Venous O₂ content)
- Requires: Spirometry (O₂ consumption), arterial blood gas, and mixed venous blood from pulmonary artery
- Gold standard, but invasive
2. Indicator Dilution Method
- A known amount of dye (e.g., Evans Blue/Indocyanine green) or cold saline is injected into a vein
- Concentration measured over time in arterial blood
- Stewart-Hamilton equation: CO = Amount of indicator / (Mean concentration × Time of passage)
- Thermodilution (most common clinical method): cold saline injected into right atrium via Swan-Ganz catheter; temperature drop measured in pulmonary artery
3. Echocardiography (Doppler method)
- Stroke volume estimated from: SV = Cross-sectional area of LVOT × Velocity-Time Integral (VTI)
- CO = SV × Heart rate
- Non-invasive, widely used
4. Impedance Cardiography (Bioimpedance)
- Measures changes in thoracic electrical impedance with each heartbeat
- Non-invasive, correlates with CO changes
- Less accurate in obese patients, arrhythmias
5. Pulse Contour Analysis
- Analyses the arterial pressure waveform to estimate SV and CO
- Less invasive than thermodilution
- e.g., PiCCO, LiDCO systems
(b) Referred Pain and Its Theories (5 marks)
Definition: Referred pain is pain perceived at a site different from the actual site of tissue damage or noxious stimulation. It is typically visceral pain referred to a somatic (cutaneous) area.
Classical Examples:
- Cardiac ischemia → Left arm, jaw, left shoulder pain
- Appendicitis → Umbilical region (T10 dermatome) initially
- Diaphragmatic irritation → Shoulder tip (C3,4,5 - phrenic nerve)
- Renal colic → Groin/testis
- Gallbladder → Right shoulder
Theories:
1. Convergence-Projection Theory (most widely accepted)
- Visceral and somatic afferents from the same spinal segment converge on the SAME second-order neuron in the dorsal horn
- The brain, which is accustomed to pain signals from the skin (somatic), "projects" the pain to that somatic area
- It CANNOT distinguish the true source (visceral) from the familiar source (skin)
2. Convergence-Facilitation Theory (MacKenzie's theory)
- Visceral pain impulses create a "facilitated" (hyperexcitable) state in dorsal horn neurons
- Normal, sub-threshold somatic inputs from the referred zone now become suprathreshold
- Even mild somatic stimuli produce pain in the referred area
- Explains cutaneous hyperalgesia and allodynia in referred pain zones
3. Axon Reflex Theory
- Visceral pain impulse travels along peripheral axon → reaches a branch point → antidromic signal travels down somatic branch → releases substance P and other mediators in skin → local inflammation → somatic pain
(c) Difference Between Pituitary Dwarfism and Thyroid Dwarfism (5 marks)
| Feature | Pituitary Dwarfism (GH Deficiency) | Thyroid Dwarfism (Cretinism - Hypothyroid) |
|---|
| Cause | Deficiency of Growth Hormone (GH) from anterior pituitary | Deficiency of thyroid hormones (T3/T4) during fetal/early postnatal life |
| Body proportions | NORMAL proportions (proportionate dwarfism) - head, trunk, limbs all uniformly small | DISPROPORTIONATE - short stature with large head, short limbs, protruding tongue |
| Mental status | Normal intelligence | Severe mental retardation (irreversible if untreated early) |
| Bone age | Delayed but proportionate | Very significantly delayed (stippled epiphyses) |
| Facial features | Normal (may have mild baby-face appearance) | Coarse facies, large tongue (macroglossia), depressed nasal bridge, hypertelorism |
| Metabolic rate | Normal BMR | Low BMR; cold intolerance, sluggishness, constipation |
| Sexual development | Delayed puberty (unless combined gonadotropin deficiency) | Delayed; may have precocious puberty (Van Wyk-Grumbach syndrome) |
| Skin/Hair | Normal | Dry, rough skin; coarse hair; myxedematous (non-pitting edema) |
| Muscle tone | Normal | Hypotonia, umbilical hernia |
| Treatment | GH replacement | Thyroid hormone replacement (must be started EARLY - before 3 months to prevent mental retardation) |
| TSH level | Normal (or elevated ACTH) | Elevated TSH (in primary hypothyroidism) |
| Insulin-like growth factor (IGF-1) | Low | Normal range |
(d) Phantom Limb (5 marks)
Definition: Phantom limb is the perception that an amputated or deafferented limb is still present and is part of the body. It occurs in virtually all amputees (60-80%).
Two components:
- Phantom sensation: Non-painful awareness of the absent limb's presence, position, or movement
- Phantom limb pain: Painful sensations (burning, cramping, shooting) perceived in the absent limb (60-80% of amputees)
Mechanism / Theories:
1. Peripheral Theory
- Neuromas (tangles of regenerating axons) form at the amputation stump
- They discharge spontaneously → sent to brain → interpreted as sensation from missing limb
- Supported by: local anesthetic injection to stump reduces phantom pain temporarily
2. Spinal (Central Sensitization) Theory
- Loss of normal afferent input → spinal neurons become hyperexcitable
- Dorsal horn neurons show "wind-up" and sensitization
- Supported by: phantom pain persists even after dorsal rhizotomy in some cases
3. Cortical Reorganization Theory (most accepted today)
- The somatosensory cortex (Penfield's homunculus) undergoes reorganization after limb loss
- Adjacent cortical areas "invade" the deafferented cortical zone
- Example: Face area expands into the arm area of S1 cortex → touching face triggers phantom arm sensation
- Supported by: neuroimaging (fMRI) studies
Clinical Features:
- Most common in arm and leg amputees
- May feel limb in abnormal position (e.g., twisted), causing distress
- Telescoping: Phantom limb feels as if it is shrinking/retracting into the stump
Treatment:
- Mirror therapy (most effective non-pharmacological)
- Prosthesis use
- TENS (transcutaneous electrical nerve stimulation)
- Pharmacological: Gabapentin, pregabalin, amitriptyline, opioids
- Graded motor imagery
(e) Impedance Matching (5 marks)
Definition: Impedance matching is the process by which the middle ear efficiently transfers sound energy (vibrations) from the low-impedance air medium to the high-impedance fluid (perilymph) of the inner ear, preventing massive energy loss.
The Problem:
- Sound travels through air (low acoustic impedance) to fluid (perilymph, high acoustic impedance)
- At an air-fluid interface, ~99.9% of sound energy is reflected (only 0.1% transmitted) - a 30 dB loss
- The middle ear overcomes this via three mechanisms:
Mechanisms of Impedance Matching:
1. Area Ratio of Tympanic Membrane to Oval Window (most important)
- Tympanic membrane area: ~55 mm²
- Footplate of stapes (oval window): ~3.2 mm²
- Ratio ≈ 17:1
- Force concentrated from large area to small area → pressure amplified ~17-fold
2. Lever Action of the Ossicular Chain
- Malleus, Incus, Stapes form a lever system
- Effective lever ratio: ~1.3:1
- Additional force amplification
3. Buckling Effect of the Tympanic Membrane
- The curved tympanic membrane buckles like a drum membrane
- Additional mechanical advantage ≈ 2-fold
Total Amplification:
- Overall pressure gain = 17 × 1.3 × 2 ≈ 44-fold (about 25-30 dB)
- This nearly compensates for the theoretical 30 dB loss at the air-fluid interface
Clinical Relevance:
- Damage to the ossicular chain (otosclerosis, trauma) → Conductive hearing loss
- Otosclerosis: Fixation of stapes footplate → impedance mismatch → up to 60 dB conductive loss
- Tympanoplasty/ossiculoplasty: Surgical procedures to restore impedance matching
- Acoustic reflex: Tensor tympani and stapedius muscles contract to stiffen the system → reduces transmission of loud sounds (protective mechanism)
All answers compiled from Guyton & Hall Medical Physiology, Gray's Anatomy for Students, Harrison's Principles of Internal Medicine, and Costanzo Physiology.